News

ivWatch Announces Federal Distribution Agreement with Marathon Medical Corp.

ivWatch, LLC, the IV safety company, today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB) focused on providing a range of medical products to Federal healthcare agencies. ivWatch’s patient monitoring technology helps protect patients from unpredictable IV complications with early IV infiltration and extravasation detection.

Under the terms of the multi-year agreement, Marathon Medical will distribute the ivWatch patient monitoring system in the United States to VA hospitals and clinics, Indian Health Service hospitals and clinics, and other Federal agencies. In conjunction with the partnership, ivWatch products will be added to Marathon’s FSS/GSA contracts, significantly increasing visibility, and providing direct access to ivWatch technology for advancing IV therapy.

With over 30 clinical studies and more than 20 years of research and development completed, ivWatch products use a predictive algorithm combined with multi-spectral light to identify extravasations at the earliest onset of fluid leaking outside of the vein. Every extravasation is a medication dosing error and can lead to severe outcomes such as nerve damage, scarring, skin necrosis, and even amputation, in the most serious instances. ivWatch and Marathon Medical will work in partnership to provide clinical vascular access education services, product evaluations for facilities to understand how the technology seamlessly integrates into their workflow, and product implementation support.

ivWatch’s president and CEO Gary Warren was particularly passionate about securing this partnership as a former 14-year federal employee of NASA and someone whose family history is deeply rooted in the military, with multiple generations having served – including three of his sons who served or are currently serving in the Navy.

“ivWatch and Marathon Medical share the same belief in the importance of standing up, speaking up and fighting for better patient safety – and that determination combined with our shared employee cultures of empathy and selflessness define our partnership,” said Warren. “I knew from the moment I walked into their headquarters and met John and his team that our collective future would involve taking immediate action in our communities – mobilizing our veterans and frontline workers and making a positive difference in IV therapy outcomes. Every day we are on a mission to end this silent extravasation epidemic and empower patients, many of whom have already endured extensive pain and hardship.”

Marathon Medical was founded in 2002 by Vietnam-era veteran John St. Leger and is committed to the patient first and foremost. The company, whose manufacturing partners include Abbott, Braun Medical, Medtronic, PDI and others, remembers, honors, and gives back to the community it serves by donating to the Navy SEAL Foundation, American Military Family, and Tails of Valor. 

Noted St. Leger, “We’re passionate about helping keep our US military, Federal employee, and Native American communities healthy and safe, and ivWatch aligns perfectly with that mission. We’re thrilled to partner with and support a fellow small business to improve IV safety through advanced technology. Together, we look forward to drastically changing the experience and outcomes of patients and improving clinical practices for frontline workers.”

To learn more about the ivWatch patient monitoring system, visit https://www.ivwatch.com/tech-overview/.

Recent News

06/23/2026

Scout Space raises Series A second close from VTC Ventures, Long Knife, and 100KM

Scout Space, a space domain awareness sensor and software provider, has announced the second close of its Series A financing, adding VTC Ventures, Long Knife and 100KM to its investor syndicate. The initial close occurred in May 2026, led by Washington Harbour Partners. The funding will accelerate deployment of Scout’s in-orbit sensor network, support upcoming

06/22/2026

Icarus Medical Secures $7.2 Million Series A to Accelerate Growth and Innovation

Icarus Medical, a Charlottesville-based med-tech company focused on advancing orthopedic bracing technology, today announced the successful close of its Series A financing round. Originally targeting $5 million, the round closed oversubscribed at $7.2 million, reflecting strong investor confidence in the company’s technology platform, market momentum, and long-term vision. Orthopedic bracing company Icarus Medical closes oversubscribed

06/16/2026

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to